Treatment-related adverse events as surrogate to response rate to immune checkpoint blockade

BACKGROUND: Immune checkpoint blockade (ICB) brings hope to many late-stage cancer patients yet its marker for response remains elusive. METHODS: We developed a hypothesis that treatment-related adverse events (TrAEs) could predict objective response rate (ORR) to ICB. We plotted ORR against corresp...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Yanyun, Chen, Yunfeng, Wang, Duoqin, Zhu, Zhidong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489750/
https://www.ncbi.nlm.nih.gov/pubmed/32925773
http://dx.doi.org/10.1097/MD.0000000000022153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489750/
https://www.ncbi.nlm.nih.gov/pubmed/32925773
http://dx.doi.org/10.1097/MD.0000000000022153

Ejemplares similares